Bank of Ann Arbor’s Novartis NVS Stock Holding History

Bank of Ann Arbor’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$516K	Buy	+3,618	New	+$549K	0.07%	149

Other funds holding NVS

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $77.1B AUM 11.99% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Natixis Advisors Boston, Massachusetts $94.1B AUM 31.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Jones Financial Companies Des Peres, Missouri $273B AUM 15.34% 1-Year Est. Return

Bank of Ann Arbor's NVS Position: Q3 2026 in Review

Bank of Ann Arbor opened a new position in Novartis (NVS) in Q3 2026: 3,618 shares worth $516K. The stake represents 0.07% of the portfolio and ranks #149 among its holdings.

1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

Bank of Ann Arbor held 3,618 shares of Novartis worth $516K as of Q3 2026.
Novartis was a new Bank of Ann Arbor position in Q3 2026.
Novartis made up 0.07% of Bank of Ann Arbor's portfolio in Q3 2026, its #149 holding.
1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Bank of Ann Arbor's 13F filing for Q3 2026, filed 13 Nov 2026.